empty

Ofatumumab

2 results found for: ofatumumab

NICE recommends new drug for relapsing MS

NICE has recommended the use of auto-injectable MS drug ofatumumab on the NHS. 

MHRA approves self-inject treatment for relapsing MS

The MHRA has approved ofatumumab for adult patients with relapsing forms of multiple sclerosis (RMS), manufacturer Novartis has announced. 



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Network News's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.